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Abstract 27 
 28 
Purpose of review:  Muscle mass and function decline progressively starting in middle age, 29 
which can result in sarcopenia and affect people’s mobility and independence late in life.  30 
Exercise training and increased protein intake are typically recommended to counteract the age-31 
associated decline in muscle mass and function.  However, few people comply with exercise 32 
recommendations and evidence for the anti-sarcopenic effectiveness of high protein intake is 33 
lacking.  This review aims to explore recent developments in the potential for fish-oil derived n-3 34 
polyunsaturated fatty acids (n-3 PUFA) to improve muscle mass and function in older people. 35 
Recent findings:  The results from recent studies demonstrate that dietary supplementation 36 
with fish oil-derived n-3 PUFA stimulates muscle protein synthesis and improves muscle mass 37 
and function in sedentary older adults and augments the resistance exercise training-induced 38 
increase in muscle strength.  The exact mechanisms by which fish oil-derived n-3 PUFAs exert 39 
their beneficial effects on muscle mass and function remain to be elucidated. 40 
Summary and Conclusion:  Fish-oil supplementation has anti-sarcopenic effects and should 41 
be considered in the clinical care of older adults. 42 
 43 
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  45 
Introduction 46 
Starting in late middle-age, skeletal muscles atrophy progressively and muscle tissue 47 
undergoes morphological changes (e.g., infiltration with non-contractile material, such as fat and 48 
connective tissue; reduced capillary density and mitochondrial content; motor unit and 49 
neuromuscular junction remodelling) which can reduce muscles’ ability to generate and maintain 50 
force, and negatively affect activities of daily living (walking, climbing stairs, lifting items) [1-3].  51 
In healthy people muscle mass and strength decline by ~0.5%-1.0% and 1%-2% per decade, 52 
respectively; periods of acute illness and chronic diseases accelerate these processes.  A 53 
decrease in muscle mass and physical abilities (walking speed and/or strength) below certain 54 
threshold values, established by the International Sarcopenia Initiative [1], is referred to as 55 
sarcopenia.  Sarcopenia is associated with a 2-3-fold increased risk of falls (~20% increase in 56 
incidence for each ~15% decrease in leg strength), frailty, disability, loss of independence, and 57 
mortality (~4% increase for every 1 kg decrease in grip strength) [1, 4-9].  Sarcopenia affects 58 
10-30% of independently living older adults, without major illness, and even more ill and/or 59 
institutionalized older adults [1, 10-12].  The total number of people affected by sarcopenia is 60 
expected to rise significantly because, according to U.S. Census Bureau Population Projections 61 
(www.agingstats.gov), the number of older adults (>65 years of age) is expected to double in 25 62 
years, until the youngest Baby Boomers” reach 65 years of age.  No safe and effective drug 63 
therapies for the prevention and treatment of sarcopenia exist.  Current recommendations, 64 
therefore, focus on exercise training and high protein intake, but these approaches have 65 
limitations as outlined below.  Fish oil-derived n-3 polyunsaturated fatty acids (n-3 PUFA) 66 
(eicosapentaenoic and docosahexaenoic acid) have emerged as a potential new treatment 67 
modality for the prevention and treatment of sarcopenia that warrant serious consideration in the 68 
clinical care for older adults. 69 
 70 
 71 
Physical activity and the risk of sarcopenia 72 
Regular physical activity, particularly resistance type exercise, is the cornerstone for maintaining 73 
adequate muscle mass and function throughout life [1, 13-15].  However, even life-long 74 
exercisers and highly trained master class athletes exhibit a progressive loss of muscle mass 75 
and function [16-18].  Moreover, a plethora of health-, environment-, and self-related factors 76 
represent barriers to initiate and continue exercise programs in the general population [19-22].  77 
Indeed, only 10% of older adults engage in physical activities that enhance and maintain 78 
strength and endurance on two or more days per week and only 15-20% make trips of one mile 79 
or less by walking [19, 23].  Muscle is very sensitive to disuse, and even short-periods of 80 
reduced use can have detrimental consequences in older adults because of the resulting loss of 81 
muscle mass (~5-8% after only 1-2 weeks of reduced ambulation) and function (~10% decrease 82 
in strength after only 4 days of immobilization) which are difficult to recover even with intense 83 
physical rehabilitation [24-26].  Accordingly, dietary changes are also recommended to mitigate 84 
the age-associated loss of muscle mass and function. 85 
 86 
Current dietary recommendations to mitigate the risk and consequences of sarcopenia 87 
International expert groups recommend a minimum protein intake of 1.0-1.2 g per kg body 88 
weight per day (which is 25%-50% more than the RDA of 0.8 g/kg/d) for healthy older adults, 89 
1.2-1.5 g/kg/d for those who have acute or chronic diseases, and up to 2.0 g/kg/d during periods 90 
of acute illness [14, 15].  However, conclusive evidence that high protein intake has meaningful 91 
effects on muscle mass and/or function is lacking [27-33].  This may in part be due to the short 92 
duration of many of the studies which have evaluated the effect of protein intake on muscle 93 
mass and strength, but also because most studies paid little attention to participants’ habitual 94 
protein intake, the source of protein and the timing of protein intake.  High intake of leucine-rich 95 
proteins, such as whey protein, evenly distributed across meals is suggested to be particularly 96 
beneficial because protein ingestion stimulates muscle protein synthesis acutely in a dose 97 
dependent manner and leucine supplementation augments the anabolic response to protein 98 
ingestion [15, 34-41].  Indeed, in one trial, it was found that adding 15 g milk protein to both 99 
breakfast and lunch, for 24 weeks, improved the Short Physical Performance Battery score [42]. 100 
Additional long-term high quality clinical trials are clearly needed in this area.  On top of this, 101 
there are potential downsides to increasing protein intake to consider.  The results from several 102 
small cross-sectional and large population studies have shown a link between high protein 103 
consumption and the development of insulin resistance and T2D [43-50].  The risk of developing 104 
T2D increases by 20-40% for every 10 g of protein consumed, in excess of 64 g/d, and the risk 105 
of developing T2D in people in the highest quartile of protein consumption is nearly twice that of 106 
those in the lowest quartile [47-49].  The potential adverse effect of high protein intake on the 107 
pathophysiological mechanisms underlying T2D has also been demonstrated in small 108 
randomized-controlled studies [51-55].  It is worth pointing out, however, that the authors of 109 
several recent systematic reviews and meta-analyses [56-59] have concluded that the available 110 
data are inadequate to determine the effect of high protein intake per se on insulin sensitivity 111 
and plasma glucose concentration, because of potential confounding influences of food 112 
selection and overall diet composition, differences between intervention and control groups, and 113 
the short duration of most trials. 114 
 115 
Fish-oil derived n-3 PUFA – a potential new treatment modality to reverse sarcopenia 116 
The results from epidemiological studies [60] and experiments in cell cultures and animals [61] 117 
suggest that fish oil-derived n-3 PUFA could have therapeutic effects in older adults.  We [62] 118 
and another group of investigators [63] found that healthy, older women who participated in an 119 
exercise training program and consumed 2-4 g fish oil per day for 3 months had greater training-120 
induced gains in muscle strength than those who did not supplement their diet with fish oil.  We 121 
also found 6 months of dietary supplementation with 4 g of fish oil-derived n-3 PUFA, increased 122 
muscle mass and strength in healthy, physically active, but untrained older adults [64].  Daily 123 
supplementation with 1.3 g of n-3 PUFA for 12 weeks, on the other hand, was not associated 124 
with improved muscle strength and global physical function in older adults [65]. The lack of an 125 
effect in this study was most likely due to both the low dose and short duration of the 126 
intervention, because we found significant increases in muscle mass and function after six but 127 
not three months of treatment with 4 g of fish oil-derived n-3 PUFA per day [64].  Unlike high 128 
protein intake, there is no evidence that these fatty acids have any adverse effects on 129 
cardiometabolic health [66-69], which supports their use in older adults who are most 130 
susceptible to cardiometabolic disease. 131 
The mechanisms responsible for the beneficial effects of fish oil-derived n-3 PUFAs on muscle 132 
mass and function have not been fully elucidated, but are likely multifactorial including several, 133 
or all of the ones outlined in Figure 1.  Changes in muscle mass result from changes in both 134 
protein turnover (balance between synthesis and breakdown) and cell turnover (balance 135 
between satellite cell proliferation and fusion and myonuclear loss).  We found that adding 4 g of 136 
fish oil-derived n-3 PUFA per day for 8 weeks to the diet of healthy older adults increased the 137 
acute amino acid induced activation of the mTOR-p70s6k signalling pathway and muscle 138 
protein synthesis [70].  Others found that adding 3.9 g of fish oil-derived n-3 PUFA to the diet of 139 
older adults augmented the acute exercise-induced increase in muscle protein synthesis [71].  140 
The effect of fish oil-derived n-3 PUFAs on muscle protein synthesis has also been investigated 141 
in young adults and the results are equivocal.  We found that 8 weeks of fish oil-derived n-3 142 
PUFA intake (4 g per d) increased the rate of muscle protein synthesis during amino acid and 143 
insulin infusion in sedentary young adults [72].  On the other hand, others found no effect of 8 144 
weeks of fish oil-derived n-3 PUFA intake (5 g per d) on the rate of muscle protein synthesis in 145 
resistance trained young men, who consumed 30 g of protein at rest or after a bout of 146 
resistance exercise [73].  This was likely because the high protein intake combined with regular 147 
exercise training already maximally stimulated muscle protein synthesis in this participant group 148 
[38].  Studies conducted in cell cultures, rats, and patients on maintenance hemodialysis found 149 
fish oil-derived n-3 PUFA also attenuated muscle protein breakdown [61].  The effect of fish oil-150 
derived n-3 PUFAs on muscle cell turnover is not known. 151 
Increased muscle function (strength and endurance) could be due to changes in myocytes 152 
themselves (myofiber microstructure, contractility, and energy production), as well as changes 153 
in external factors (extracellular matrix composition and function, muscle perfusion, and 154 
neuromuscular function).  The results from several studies suggest a coordinated response of 155 
several (or all) of these factors might be involved, but this has never been comprehensively 156 
evaluated in people.  We found that fish oil-derived n-3 PUFA supplementation in healthy older 157 
adults increased the expression of genes involved in muscle mitochondrial function [74], and 158 
others found, although not consistently, it reduces oxidant emission [71] and ADP sensitivity [75] 159 
in mitochondria isolated from human muscle.  Rats fed fish oil-derived n-3 PUFAs were found to 160 
use less oxygen for tension development and were able to work harder, and fatigued later than 161 
those fed the control diet [76].  In healthy people participating in an exercise training program, 162 
fish oil supplementation shortened the electromechanical delay and increased the rate of force 163 
development during maximal voluntary isometric contractions [63], and adding fish oil to the diet 164 
of mice and rats improved their motor and sensory nerve conduction speed and protected them 165 
from developing diabetic peripheral neuropathy [77, 78].  Studies conducted in rats and healthy 166 
middle-aged people found that fish-oil derived n-3 PUFAs augment brachial artery dilation, 167 
vascular conductance, and blood flow [79, 80]. It is therefore likely that several mechanisms 168 
contribute to the beneficial effect of fish oil-derived n-3 PUFA on muscle function and further 169 
work is needed to investigate this in people. 170 
 171 
 172 
 173 
Summary 174 
An effective approach to prevent and treat age-associated sarcopenia is much needed.  Regular 175 
physical activity and exercise training have potent anti-sarcopenic effects but are difficult to 176 
implement.  The current recommendation for increased protein intake is not evidence-based, 177 
and could have adverse “side-effects” on cardiometabolic health.  Dietary supplementation with 178 
≥2 g of fish oil-derived n-3 PUFAs per day has been found to increase muscle protein synthesis 179 
and muscle mass and function in healthy untrained and exercise training older adults but the 180 
mechanisms mediating the beneficial effects of fish oil-derived n-3 PUFAs on muscle mass and 181 
function have not been fully elucidated. 182 
 183 
Conclusion 184 
The results from studies conducted in healthy and exercise training older adults support the use 185 
of fish oil-derived n-3 PUFA as a new treatment modality for the prevention and treatment of 186 
sarcopenia.  Interdisciplinary basic and clinical and translational studies are needed to explore 187 
the multifactorial mechanisms responsible for the beneficial effects of fish oil-derived n-3 PUFAs 188 
on muscle mass and function. 189 
  190 
Key points 191 
 Ageing is associated with a progressive decrease in muscle mass and function, which can 192 
have deleterious consequences affecting people’s mobility and independence. 193 
 There are currently no effective pharmacological treatments for the treatment and 194 
prevention of sarcopenia; lifestyle changes, such as resistance exercise training and high 195 
protein intake, are therefore promoted albeit with limited success because of low adherence 196 
to exercise and uncertainties concerning the effectiveness of high protein intake elicit the 197 
desired increase in muscle mass and function. 198 
 The results from recent studies suggest that dietary supplementation with fish oil-derived n-3 199 
PUFA improves muscle mass and function in both sedentary and exercise training older 200 
adults. 201 
 The exact mechanisms by which fish oil-derived n-3 PUFAs exert their beneficial effects on 202 
muscle mass and function remain to be elucidated. 203 
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Figure legend 217 
 218 
Figure 1.  Potential mechanisms responsible for the beneficial effects of fish oil-derived n-3 219 
polyunsaturated fatty acids on muscle mass and function.  See text for details. 220 
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Figure 1. Potential mechanisms responsible for the beneficial effects of fish oil-
derived n-3 polyunsaturated fatty acids on muscle mass and function.  See text 
for details.
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